DarioHealth Corp.
DRIO
$11.94
-$0.03-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.55% | -14.16% | 17.26% | 110.29% | 111.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.55% | -14.16% | 17.26% | 110.29% | 111.00% |
| Cost of Revenue | -17.76% | -12.97% | -7.77% | -11.14% | 22.20% |
| Gross Profit | -38.79% | -14.84% | 32.32% | 343.82% | 204.25% |
| SG&A Expenses | -12.33% | -30.44% | -32.70% | -1.63% | -0.29% |
| Depreciation & Amortization | -86.53% | -64.88% | -24.76% | 16.56% | 21.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.51% | -35.09% | -31.56% | 4.74% | 2.04% |
| Operating Income | 21.16% | 43.18% | 47.30% | 22.35% | 22.62% |
| Income Before Tax | 15.21% | 4.56% | -0.39% | 33.36% | 21.54% |
| Income Tax Expenses | -- | -- | 101.10% | 142.19% | -- |
| Earnings from Continuing Operations | 15.12% | 4.56% | -28.60% | 32.57% | 21.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.12% | 4.56% | -28.60% | 32.57% | 21.62% |
| EBIT | 21.16% | 43.18% | 47.30% | 22.35% | 22.62% |
| EBITDA | 9.74% | 41.49% | 50.67% | 34.35% | 30.80% |
| EPS Basic | 39.75% | -109.14% | 28.57% | 70.11% | 50.20% |
| Normalized Basic EPS | 45.39% | 23.40% | 27.00% | 77.26% | 44.06% |
| EPS Diluted | 39.75% | -109.14% | 28.57% | 70.11% | 50.20% |
| Normalized Diluted EPS | 45.39% | 23.40% | 27.00% | 77.26% | 44.06% |
| Average Basic Shares Outstanding | 55.28% | 24.60% | 37.54% | 172.91% | 40.26% |
| Average Diluted Shares Outstanding | 55.28% | 24.60% | 37.54% | 172.91% | 40.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |